Ownership history in Jackson Square Partners, LLC Β· 32 quarters on record
This page tracks every 13F SEC filing in which Jackson Square Partners, LLC reported a position in CME GROUP INC (CME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Jackson Square Partners, LLC outperformed the S&P 500 by +5.8% annually on this CME position. Timing score: 29% (9/31 decisions correct). Average cost basis: $76.44. Maximum drawdown during holding period: β21.2%.
π₯ Exceptional β beat the S&P 500 by 5.8% per year on this position.
31 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
9 of 31 add/trim decisions correct
Best entry: $43.97 (2014 Q2) Β· Worst: $157.06 (2019 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
5 adds Β· 26 trims. Bought during 2 of 8 down-price quarters. π Predominantly trimming β distribution phase.
π Jackson Square Partners, LLC has been actively increasing its CME allocation β a bullish signal from insiders.
Currently 1.75% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size